ChromaDex
- Headquarters
- Los Angeles, California
- Business Model
- B2C
- Website
- chromadex.com
About
Global leader in NAD+ science and healthy-aging research; publicly traded company rebranded as Niagen Bioscience (NASDAQ: NAGE).
Summary
ChromaDex is a Biotech company based in Los Angeles, United States.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA
Global fertility clinics platform
Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
inVentiv HealthAcquired
Biopharmaceutical services company
Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
Altos Labs
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022
Warner ChilcottClosed
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
BeiGeneIPO
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Cambridge, United States10001+Biotech, Oncology
Corporate Round·$2.8B·Jan 2020